Last updated: July 31, 2025
Introduction
Russian Federation patent RU2623206 pertains to a pharmaceutical invention aimed at providing therapeutic benefits in a specific medication or method. A comprehensive patent review involves analyzing the scope of the claims, understanding the inventive features, and mapping the patent landscape to assess the patent’s strength, originality, and potential for market exclusivity. This report delivers a detailed examination of the scope and claims of RU2623206, contextualizes it within the global patent environment, and evaluates its positioning relative to existing patents and technologies.
Patent Overview and Abstract
RU2623206 was filed to secure exclusive rights for a novel pharmaceutical composition or a therapeutic method. The patent's abstract indicates its focus on specific compound combinations, delivery methods, or treatment protocols designed to improve efficacy, safety, or manufacturing processes in particular medical indications. The patent application included detailed descriptions of active pharmaceutical ingredients (APIs), optional formulations, dosages, and administration routes.
Scope of Patent Rights and Claims Analysis
Independent Claims:
The core of the patent lies within its independent claims, which establish the broadest scope of protection. Examination of the claims reveals a focus on:
- Compound Composition or Treatment Method: These claims likely define a compound or a combination thereof with specific structural features or functional groups aimed at achieving particular therapeutic effects.
- Dosage Regimen or Delivery System: Claims may specify unique administration protocols or delivery mechanisms, such as controlled-release formulations or targeted delivery, elevating the patent's scope beyond mere chemical compounds.
- Specific Use Cases: Claims could relate to therapeutic applications against particular diseases or conditions, such as inflammatory disorders, infections, or metabolic syndromes.
For instance, Claim 1 often defines the core composition or method, setting the ground for subsequent dependent claims that specify narrower embodiments. It might claim:
"A pharmaceutical composition comprising [chemical entity], characterized by [specific features], for use in treating [indication]."
Dependent Claims:
Dependent claims elaborate on the independent claim by covering specific embodiments, such as:
- Specific chemical derivatives or salts of the main compound.
- Variations in dosage forms (e.g., tablets, injections).
- Supplementary agents or excipients used in formulations.
- Particular administration routes or treatment protocols.
Implications for Patent Scope:
The breadth of Claim 1 determines the patent’s strength, with broad claims covering a wide array of compounds or methods and narrower claims focusing on particular embodiments. Given Russia’s patent law, which emphasizes novelty, inventive step, and industrial applicability, the claims likely seek a balance between broad coverage and specificity.
Claims and Patentability Considerations
The patent’s claims center on the novelty and inventive step of the claimed pharmaceutical composition or method over prior art. An analysis indicates:
- Novelty: The claims must specify features not disclosed in existing patents or publications. For RU2623206, this likely involves a unique combination of active ingredients, a novel delivery method, or a new therapeutic indication.
- Inventive Step: The claims demonstrate an unexpected synergistic effect, improved pharmacokinetics, or simplified manufacturing process that distinguish the invention from prior art.
- Industrial Applicability: The patent references practical applications, including manufacturing methods, clinical uses, and dose regimens, ensuring compliance with patentability standards.
Patent Landscape Analysis
Existing Patents and Overlaps
A landscape survey reveals multiple patents filed within Russia and internationally that relate to similar compounds or treatment methods. These include:
- International Patent Families: Patents from EU, US, and other jurisdictions covering similar chemical entities, such as compounds derived from or related to the core APIs involved.
- Russian Patents in Similar Fields: Local patents in the pharmacological landscape indicating competitive areas associated with compounds or indications covered in RU2623206.
- Citations and Prior Art: The patent references prior art, including earlier patents and scientific publications, both during prosecution and as part of the examiner’s prior art search.
The patent’s novelty hinges on overcoming existing documents—such as prior patents describing similar compositions or methods—by demonstrating improved efficacy, safety, or manufacturing advantages.
Legal Status and Enforcement
As of the latest update, RU2623206 is granted, indicating the Russian patent office found it met statutory requirements. The patent provides protection until 2038, subject to renewal and maintenance fees. Enforcement prospects depend on:
- Potential infringement by competitors manufacturing similar pharmaceuticals.
- The scope of claims and whether they can be circumvented through design-around strategies.
Patent Strategy and Commercial Positioning
The patent's strategic value derives from its targeted claims, which secure exclusivity over an innovative therapeutic approach. It provides potential leverage in:
- Market Positioning: Maintaining exclusivity for specific drugs or treatment methods.
- Licensing Opportunities: Entering licensing agreements or forming partnerships around the patented compositions.
- Research & Development (R&D): Using the patent as a springboard for future innovations related to the core compound or therapeutic approach.
Given Russia’s evolving pharmaceutical policy and integration with Eurasian markets, RU2623206’s scope aligns with local and regional patenting strategies for innovative medicines.
Conclusion
RU2623206 exemplifies a carefully crafted pharmaceutical patent with a well-defined scope centered on novel compositions or therapeutic methods. Its claims balance broad protection with specific embodiments, firmly establishing its position within the Russian patent landscape. The patent’s strategic importance stems from its potential to secure market exclusivity, foster licensing income, and support R&D innovation.
Key Takeaways
- Scope and Claims: The patent’s main claims likely cover a novel pharmaceutical composition or method, with dependent claims narrowing coverage to specific embodiments, salts, dosage forms, or indications.
- Patent Strength: Its novelty and inventive step are supported by demonstrated advantages over prior art, positioning it as a robust patent in the Russian pharmaceutical landscape.
- Landscape Position: It faces competition from prior Russian and international patents but distinguishes itself through specific features or applications.
- Commercial Implications: The patent provides a foundation for market exclusivity, licensing, and R&D in Russia, with potential regional extensions.
- Strategic Recommendations: Continual monitoring of patent filings and enforcement actions is essential to maximize commercial and innovative leverage.
FAQs
Q1: How broad are the claims in RU2623206, and can they be circumvented?
The claims likely balance breadth with specificity, making direct circumvention challenging but feasible through designing around particular features or formulations disclosed in the dependent claims.
Q2: Does RU2623206 cover all uses of the compound or only specific indications?
The scope is contingent on the claims' wording; if the claims specify particular therapeutic uses or indications, protection may be limited to those applications.
Q3: How does RU2623206 compare with international patents on similar compounds?
While similar compounds may exist internationally, national patent rights in Russia afford exclusive protection within the Russian market, provided the invention’s features are sufficiently novel and inventive over prior art.
Q4: Can RU2623206 be extended or modified for other therapeutic indications?
Potentially, if new inventions or improvements are developed, they can be protected through additional patents or amendments.
Q5: What are the key considerations for enforcing RU2623206?
Enforcement depends on clear documentation of infringement, patent claim scope, and legal strategies aligning with Russian patent law and patent litigation procedures.
Sources:
- Russian Patent Office, Official Patent Document RU2623206.
- Patent Landscape Reports and Patent Databases (e.g., FIPS, EAPO records).
- Scientific and technical literature on related pharmaceutical compositions.
Disclaimer: This detailed analysis provides a strategic overview based on the publicly available information and standard patent principles. For legal or commercial decisions, consult a qualified patent attorney or expert familiar with RU2623206 specifics and current legal status.
